Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome

R. Jaffe, J. Abramowicz, N. Eckstein, I. Vagman, M. Fejgin, D. Ayalon

Research output: Contribution to journalArticlepeer-review

Abstract

Polycystic ovarian disease is characterized by menstrual disorders, infertility, obesity, and large ovaries. Large ovaries with multiple cysts are the direct cause of the high incidence of ovarian hyperstimulation during ovulation induction. Lately, gonadotropin-releasing hormone (GnRH) analogues have been employed to decrease ovarian steroidogenesis and thus reduce the incidence of ovarian hyperstimulation. In this study the ovarian size was ultrasonographically assessed during chronic GnRH analogue treatment, revealing a significant reduction in ovarian volume. This decrease in volume results in a reduced incidence of hyperstimulation, and we think the ultrasonic scanning can be effectively used to assess the success of GnRH treatment.

Original languageEnglish
Pages (from-to)203-206
Number of pages4
JournalJournal of Ultrasound in Medicine
Volume7
Issue number4
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome'. Together they form a unique fingerprint.

Cite this